UK adopts new AI health regulation to fast-track NHS testing and attract innovators

On Tuesday the UK government endorsed every recommendation from the National Commission into the Regulation of AI in Healthcare, paving the way for a major overhaul of how AI-based medical devices are approved and supervised. The MHRA will replace the traditional one-off assessment with a lifecycle-based framework that monitors performance throughout a device’s use, and it has opened applications for the third phase of its AI "airlock" sandbox to test products alongside regulators.

Proponents argue the model gives UK firms a competitive edge by enabling early proof of concept in the NHS, potentially attracting more investment and acquisitions. However, both Martin Turner of the Bioindustry Association and Steve Lee of the Association of British Healthtech Industries cautioned that regulatory oversight must not become a perpetual burden and that real commercial growth depends on NHS adoption and reimbursement. Health innovation minister James Frith emphasized that patient safety must remain paramount despite the push for faster innovation.